Pharmacological Treatment of Depression

Article information

J Korean Med Assoc. 2003;46(1):69-75

Publication date (electronic) : 2003 January 31

doi : https://doi.org/10.5124/jkma.2003.46.1.69

Department of Neuropsychiatry, Korea University College of Medicine, Anam Hospital, Korea. leeminso@korea.ac.kr

Abstract

This paper is to summarize the specific form of pharmacological treatments that have been developed to deal with depressive disorder. Specific antidepressants including monoamine oxidase inhibitors(MAOIs), tricyclic antidepressants(TCAs), selective serotonin reuptake inhibitors(SSRIs), norepinephrine and dopamine reuptake blockers(NDRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), serotonin-2 antagonist/reuptake inhibitors (SARI), noradrenergic and specific serotonergic antidepressant (NaSSA) and selective serotonin reuptake enhancer (SSRE) are reviewed. There are several side effects of antidepressants that should be considered, such as dizziness, sedation, anticholinergic effect, weight gain, sexual dysfunction, cardiovascular effect, insomnia, anxiety, etc. Treatment courses of depressive disorder can be divided into remission in acute phase, continuation phase, and maintenance period, so that medication of antidepressants should be optimized for each phases.

Keywords: Depression; Pharmacological Approach; Side effects

References

1. American Psychiatric Association. Practice guidelines 1996. Washington, DC: American Psychiatric Association;

2. Cunningham LA, Borison RL, Carman JS, Chouinard G, Crowder JE, Hearst E, et al. A comparison of venlafaxin, trazodone, and placebo in major depression. J Clin Psychopharmacol 1994. 1499–106.

3. Prien RF, Kupfer DJ. Continuation drug therapy for major depressive episodes; how long shold it be maintained? Am J Psychiatry 1986. 14318–23.

4. Quitkin FM, Rabkin JG, Markowitz JM, Stewart JW, McGrath PJ, Harrison W. Use of pattern analysis to identify true drug response. Arch Gen Psychiatry 1987. 44259–264.

5. Stahl SM. Essential psychopharmacology: Neuroscientific basis and clinical application 1996. New York: Cambridge university press;

Article information Continued

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.